Location: 4F Katie Colleen A. Maletich, MBA, BSN, RN – Seattle Cancer Care Alliance; Brandelyn Bergstedt – Seattle Cancer Care Alliance; Thomas H. Gallagher, MD – University of Washington; Stephen E. Lovell, MS – Seattle Cancer Care Alliance
Katie Colleen A. Maletich, MBA, BSN, RN – Seattle Cancer Care Alliance ### 802174###Speaker @@@ Brandelyn Bergstedt – Seattle Cancer Care Alliance ### 802176###Speaker @@@ Thomas H. Gallagher, MD – University of Washington ### 802175###Speaker @@@ Stephen E. Lovell, MS – Seattle Cancer Care Alliance ### 802177###Speaker
Location: 4C R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA – Winship Cancer Institute of Emory University; Colleen Lewis, MSN, ANP-BC, AOCNP – Winship Cancer Institute of Emory University
R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA – Winship Cancer Institute of Emory University ### 161963###Speaker @@@ Colleen Lewis, MSN, ANP-BC, AOCNP – Winship Cancer Institute of Emory University ### 761835###Speaker
Matthew Lunning, DO, FACP – University of Nebraska Medical Center ### 799113###Speaker @@@ Katherine L. Byar, MSN, ANP, BC, BMTCN – Nebraska Medicine ### 799114###Speaker
Lee S. Schwartzberg, MD, FACP – West Cancer Center ### 235390###Speaker @@@ Heather R. Greene, MSN, FNP, AOCNP® – West Cancer Center and Research Institute ### 235381###Speaker
Lee S. Schwartzberg, MD, FACP – West Cancer Center ### 235390###Speaker @@@ Heather R. Greene, MSN, FNP, AOCNP® – West Cancer Center and Research Institute ### 235381###Speaker
5:45 PM - 7:45 PM
Certified Dinner Symposium: Creating Clarity in Metastatic Melanoma: Optimizing Treatment and Improving Outcomes (This activity is supported by an educational grant from Array BioPharma Inc., Bristol-Myers Squibb Company, and Merck Sharp & Dohme Corp.) Ticketed event. Limited seating
Anthony J. Olszanski, MD, RPh – Fox Chase Cancer Center ### 161961###Speaker @@@ Amanda M. Viereck, PA-C – Fox Chase Cancer Center ### 802183###Speaker
5:45 PM - 7:45 PM
Certified Dinner Symposium: First-Line Therapy for Metastatic Non-Small Cell Lung Cancer: State-of-the-Art Targeted Therapy and Immunotherapy Approaches (This activity is supported by an educational grant from AstraZeneca.) Ticketed event. Limited seating
